. . . . . . . . . . . . . . "a(SCHEM:\"LDL(-)\") -| tscript(p(MGI:Ppara))" . "Approximately 61,000 statements." . "Copyright (c) 2011-2012, Selventa. All rights reserved." . "BEL Framework Large Corpus Document" . . "1.4" . "LDL(-) stimulation led to a modest 3-fold Ppara ligand binding domain activation; in the presence of LPL and LDL(-), PPARa activation increased 30-fold....This LPL treatment may have produced greater amounts of the ligands already present in LDL(–), converted less potent ligands to more potent forms, or both....To identify this PPAR?-activating component in LDL(–), hydrolytic products of LPL-treated LDL(–) were extracted and separated using HPLC-MS. The major lipophylic compounds in LDL(–), either with or without LPL treatment, were HpODE and HODE acids" . . "Selventa" . . . . "2014-07-03T14:30:14.910+02:00"^^ . . .